Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Stefan K. Weidt"'
Autor:
Edubiel A Alpizar-Sosa, Nur Raihana Binti Ithnin, Wenbin Wei, Andrew W Pountain, Stefan K Weidt, Anne M Donachie, Ryan Ritchie, Emily A Dickie, Richard J S Burchmore, Paul W Denny, Michael P Barrett
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 9, p e0010779 (2022)
Amphotericin B is increasingly used in treatment of leishmaniasis. Here, fourteen independent lines of Leishmania mexicana and one L. infantum line were selected for resistance to either amphotericin B or the related polyene antimicrobial, nystatin.
Externí odkaz:
https://doaj.org/article/d236c07b263b428594e99eab4248e1b2
Autor:
Cecilia P. Sanchez, Erin D. T. Manson, Sonia Moliner Cubel, Luis Mandel, Stefan K. Weidt, Michael P. Barrett, Michael Lanzer
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 4 (2022)
ABSTRACT The chloroquine resistance transporter, PfCRT, is an essential factor during intraerythrocytic development of the human malaria parasite Plasmodium falciparum. PfCRT resides at the digestive vacuole of the parasite, where hemoglobin taken up
Externí odkaz:
https://doaj.org/article/d2073372fc434f7889e68c2ee165d4ee
Autor:
Andrew W Pountain, Stefan K Weidt, Clément Regnault, Paul A Bates, Anne M Donachie, Nicholas J Dickens, Michael P Barrett
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 13, Iss 2, p e0007052 (2019)
Amphotericin B is an increasingly important tool in efforts to reduce the global disease burden posed by Leishmania parasites. With few other chemotherapeutic options available for the treatment of leishmaniasis, the potential for emergent resistance
Externí odkaz:
https://doaj.org/article/02c7db962fdf4558835e9797401ea3bc
Autor:
Roy Mwenechanya, Julie Kovářová, Nicholas J Dickens, Manikhandan Mudaliar, Pawel Herzyk, Isabel M Vincent, Stefan K Weidt, Karl E Burgess, Richard J S Burchmore, Andrew W Pountain, Terry K Smith, Darren J Creek, Dong-Hyun Kim, Galina I Lepesheva, Michael P Barrett
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 11, Iss 6, p e0005649 (2017)
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administration of the drug in its liposomal formulation as a single injection is being promoted in a campaign to bring the leishmaniases under control. Understandi
Externí odkaz:
https://doaj.org/article/6745f44e729541bfb242217950694ec9
Autor:
Edubiel A. Alpizar-Sosa, Nur Raihana Binti Ithnin, Wenbin Wei, Andrew W. Pountain, Stefan K. Weidt, Anne M. Donachie, Ryan Ritchie, Emily A. Dickie, Richard J. S. Burchmore, Paul W. Denny, Michael P. Barrett
Publikováno v:
PLOS Neglected Tropical Diseases, 2022, Vol.16(9), pp.e0010779 [Peer Reviewed Journal]
Amphotericin B is increasingly used in treatment of leishmaniasis. Here, fourteen independent lines of Leishmania mexicana and one L. infantum line were selected for resistance to either amphotericin B or the related polyene antimicrobial, nystatin.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::211f168830cff69dc45cb173585a9956
http://dro.dur.ac.uk/37233/
http://dro.dur.ac.uk/37233/
Autor:
Edubiel A. Alpizar-Sosa, Nur Raihana Binti Ithnin, Wenbin Wei, Andrew W. Pountain, Stefan K. Weidt, Anne M. Donachie, Ryan Ritchie, Emily A. Dickie, Richard J. S. Burchmore, Paul W. Denny, Michael P. Barrett
Amphotericin B is increasingly used in treatment of leishmaniasis. Here, fourteen independent lines of Leishmania mexicana and one L. infantum line were selected for resistance to either amphotericin B or the related polyene antimicrobial, nystatin.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33a4174b5f5c9a2005e18edfe3074226
https://doi.org/10.1101/2021.12.08.471712
https://doi.org/10.1101/2021.12.08.471712
Autor:
Darren J Creek, Muriel Mazet, Fiona Achcar, Jana Anderson, Dong-Hyun Kim, Ruwida Kamour, Pauline Morand, Yoann Millerioux, Marc Biran, Eduard J Kerkhoven, Achuthanunni Chokkathukalam, Stefan K Weidt, Karl E V Burgess, Rainer Breitling, David G Watson, Frédéric Bringaud, Michael P Barrett
Publikováno v:
PLoS Pathogens, Vol 11, Iss 3, p e1004689 (2015)
Metabolomics coupled with heavy-atom isotope-labelled glucose has been used to probe the metabolic pathways active in cultured bloodstream form trypomastigotes of Trypanosoma brucei, a parasite responsible for human African trypanosomiasis. Glucose e
Externí odkaz:
https://doaj.org/article/6f5a415b91f34ce6b29b7e4fca138d7b
Autor:
Andrew W, Pountain, Stefan K, Weidt, Clément, Regnault, Paul A, Bates, Anne M, Donachie, Nicholas J, Dickens, Michael P, Barrett
Publikováno v:
PLoS Neglected Tropical Diseases
Amphotericin B is an increasingly important tool in efforts to reduce the global disease burden posed by Leishmania parasites. With few other chemotherapeutic options available for the treatment of leishmaniasis, the potential for emergent resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e86789998e363aa1f9394063f49385cf
https://pubmed.ncbi.nlm.nih.gov/30716073
https://pubmed.ncbi.nlm.nih.gov/30716073
Autor:
Tulloch, Lindsay B.1 (AUTHOR), Tinti, Michele1 (AUTHOR), Wall, Richard J.1 (AUTHOR), Weidt, Stefan K.2 (AUTHOR), Corpas- Lopez, Victoriano1 (AUTHOR), Dey, Gourav1 (AUTHOR), Smith, Terry K.3 (AUTHOR), Fairlamb, Alan H.1 (AUTHOR), Barrett, Michael P.2,4 (AUTHOR), Wyllie, Susan1 (AUTHOR) s.wyllie@dundee.ac.uk
Publikováno v:
PLoS Pathogens. 7/11/2024, Vol. 20 Issue 7, p1-23. 23p.
Publikováno v:
Chemical Communications; Apr2007, Vol. 2007 Issue 17, p1719-1721, 3p